Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-hodgkin lymphoma
Robert Rifkin, Gary Spitzer, Gregory Orloff, Romeo Mandanas, Dean McGaughey, Feng Zhan, Kristi A. Boehm, Lina Asmar, Roy Beveridge
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-hodgkin lymphoma'. Together they form a unique fingerprint.